Effects of simvastatin on apolipoprotein M in vivo and in vitro

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Zhang, Xiaoying ^a   Mao, Shubing ^a   Luo, Guanghua ^a   Wei, Jiang ^a   Berggren Söderlund, Maria ^b   Nilsson Ehle, Peter ^b   Xu, Ning ^b  

^a SOOCHOW UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN M; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; SIMVASTATIN; TRIACYLGLYCEROL; APOLIPOPROTEIN; APOLIPOPROTEIN M, MOUSE; LIPID;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG MEGADOSE; FAT INTAKE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION; GENETICS;

ANIMALIA; MUS;

ANIMALS; APOLIPOPROTEINS; DIETARY FATS; GENE EXPRESSION; HEP G2 CELLS; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MICE; SIMVASTATIN;

EID: 79959824875     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-112     Document Type: Article

References (21)

1. A novel human apolipoprotein (apoM). N Xu B Dahlback, J Biol Chem 1999 274 44 31286 31290 10.1074/jbc.274.44.31286 10531326
2. Isolation and characterization of human apolipoprotein M-containing lipoproteins. C Christoffersen LB Nielsen O Axler A Andersson AH Johnsen B Dahlback, J Lipid Res 2006 47 8 1833 1843 10.1194/jlr.M600055-JLR200 16682745 (Pubitemid 44222834)
3. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. C Christoffersen H Obinata SB Kumaraswamy S Galvani J Ahnstrom M Sevvana C Egerer-Sieber YA Muller T Hla LB Nielsen B Dahlbäck, Proc Natl Acad Sci USA 2011
4. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. C Wolfrum MN Poy M Stoffel, Nat Med 2005 11 4 418 422 10.1038/nm1211 15793583 (Pubitemid 40562332)
5. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. C Christoffersen M Jauhiainen M Moser B Porse C Ehnholm M Boesl B Dahlback LB Nielsen, J Biol Chem 2008 283 4 1839 1847 18006500
6. Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1. N Venteclef A Haroniti JJ Tousaint I Talianidis P Delerive, J Biol Chem 2008 283 7 3694 3701 17977826
7. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994 344 8934 1383 1389 7968073
8. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects. N Xu P Nilsson-Ehle B Ahren, J Nutr Biochem 2004 15 10 579 582 10.1016/j.jnutbio.2004.03.001 15542348 (Pubitemid 39470211)
9. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. S Richter DQ Shih ER Pearson C Wolfrum SS Fajans AT Hattersley M Stoffel, Diabetes 2003 52 12 2989 2995 10.2337/diabetes.52.12.2989 14633861 (Pubitemid 37466870)
10. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells. N Xu M Hurtig XY Zhang Q Ye P Nilsson-Ehle, Biochim Biophys Acta 2004 1683 1-3 33 37 15238217 (Pubitemid 38844657)
11. Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response. N Venteclef JC Smith B Goodwin P Delerive, Mol Cell Biol 2006 26 18 6799 6807 10.1128/MCB.00579-06 16943422 (Pubitemid 44387630)
12. Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M. C Wolfrum JJ Howell E Ndungo M Stoffel, J Biol Chem 2008 283 24 16940 16949 10.1074/jbc.M801930200 18381283
13. The effect of the HMG-CoA reductase inhibitor simvastatin and of cholestyramine on hepatic apolipoprotein mRNA levels in the rat. A Mitchell N Fidge P Griffiths, Biochim Biophys Acta 1993 1167 1 9 14 8461338 (Pubitemid 23083030)
14. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. P Chomczynski N Sacchi, Anal Biochem 1987 162 1 156 159 2440339 (Pubitemid 17064313)
15. The evolving role of statins in the management of atherosclerosis. CJ Vaughan AM Gotto Jr CT Basson, J Am Coll Cardiol 2000 35 1 1 10 10.1016/S0735-1097(99)00525-2 10636252 (Pubitemid 30061252)
16. Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes. V Bonn RC Cheung B Chen C Taghibiglou SC Van Iderstine K Adeli, Atherosclerosis 2002 163 1 59 68 10.1016/S0021-9150(01)00754-7 12048122 (Pubitemid 34615726)
17. Characterization of apoM in normal and genetically modified mice. K Faber O Axler B Dahlback LB Nielsen, J Lipid Res 2004 45 7 1272 1278 10.1194/jlr.M300451-JLR200 15102887 (Pubitemid 38802630)
18. Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus. MC Camus MJ Chapman P Forgez PM Laplaud, J Lipid Res 1983 24 9 1210 1228 6631247 (Pubitemid 14236572)
19. Diet and murine atherosclerosis. GS Getz CA Reardon, Arterioscler Thromb Vasc Biol 2006 26 2 242 249 16373607 (Pubitemid 43732181)
20. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. YX Wang B Martin-McNulty LY Huw V da Cunha J Post J Hinchman R Vergona ME Sullivan W Dole K Kauser, Atherosclerosis 2002 162 1 23 31 10.1016/S0021-9150(01)00678-5 11947894 (Pubitemid 34327338)
21. Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering. F Bea E Blessing B Bennett M Levitz EP Wallace ME Rosenfeld, Arterioscler Thromb Vasc Biol 2002 22 11 1832 1837 10.1161/01.ATV.0000036081.01231.16 12426212 (Pubitemid 35315769)